All data are based on the daily closing price as of July 18, 2024
s

Seegene

096530.KQ
15.62 USD
0.12
+0.77%

Overview

Last close
15.62 usd
Market cap
721.97M usd
52 week high
21.57 usd
52 week low
13.86 usd
Target price
37.65 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.7941
Price/Book Value
0.992
Enterprise Value
448.08M usd
EV/Revenue
1.7431
EV/EBITDA
9.1455

Key financials

Revenue TTM
265.65M usd
Gross Profit TTM
358.81M usd
EBITDA TTM
26.61M usd
Earnings per Share
N/A usd
Dividend
0.58 usd
Total assets
929.28M usd
Net debt
N/A usd

About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
  • Symbol
    096530.KQ
  • Exchange
    KQ
  • Isin
    KR7096530001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Dr. Jong-Yoon Chun
  • Headquarter
    Seoul
  • Web site
    https://www.seegene.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top